Labshake search
Citations for Tocris :
251 - 300 of 667 citations for Ethyl 5 4 methoxyphenyl 5 oxovalerate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... was dissolved in 5% DMSO (Tocris Bioscience, Cat#: 3176; Batch: 68A) containing PBS (Corning ...
-
bioRxiv - Neuroscience 2024Quote: ... and 50µM D-AP5 (D-2-amino-5-phosphonovalerate, Tocris 0106). Neurons were voltage clamped at -70mV ...
-
bioRxiv - Biochemistry 2024Quote: ... 25 μM d-(−)-2-amino-5-phosphonovaleric acid (D-AP5, Tocris), and 100 μM picrotoxin (Nacalai Tesque ...
-
bioRxiv - Cell Biology 2023Quote: ... For drug treatments: AACOCF3 (selective phospholipase A2 inhibitor, Tocris #1462-5), CK666 (selective Arp2/3 inhibitor ...
-
bioRxiv - Neuroscience 2022Quote: ... D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105), and BI2536 (Selleckchem #S1109) ...
-
bioRxiv - Neuroscience 2023Quote: ... and Clozapine N-oxide dihydrochloride (CNO, 5 mg/kg, Tocris Bioscence) were dissolved in sterile 0.9% NaCl (saline) ...
-
bioRxiv - Cell Biology 2023Quote: ... 0.1 mM 8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt (Tocris) and 0.1 mM 3-Isobutyl-1-methylxanthine (Sigma-Aldrich) ...
-
HOIL-1L deficiency induces cell cycle alteration which causes immaturity of myocyte and fibrogenesisbioRxiv - Cell Biology 2023Quote: ... The medium was supplemented with 5 μM Y27632 (TOCRIS, Cat.# 1254), a Rho-associated kinase inhibitor ...
-
bioRxiv - Biochemistry 2023Quote: ... 5% CO2 with either DMSO or MLi-2 (Tocris; 2 μM) for 1 hour ...
-
bioRxiv - Cell Biology 2023Quote: ... 0.1 mM 8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt (Tocris) and 0.1 mM 3-Isobutyl-1-methylxanthine (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2024Quote: ... Cytoplasmic dynein was inhibited using 5 µM Dynapyrazole A (Tocris, #6896).
-
bioRxiv - Developmental Biology 2024Quote: ... and 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI) (10 µM, TOCRIS) were used to activate and inhibit PLD ...
-
bioRxiv - Neuroscience 2024Quote: ... Pharmacological blockers used were as follows: CPP (5 μM; Tocris Bioscience), NBQX (10 μM ...
-
bioRxiv - Neuroscience 2024Quote: ... mGluR2/3s were blocked using LY 341495 (1-5 µM, Tocris). AMPARs were blocked using NBQX (5 µM ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... Naloxone hydrochloride (20 µg/5 µL, i.pl.; Tocris, Minneapolis, MN, US) was dissolved in sterile 0.9% NaCl ...
-
bioRxiv - Cell Biology 2024Quote: ... D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50 µM, Tocris), 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX 20 µM ...
-
bioRxiv - Genetics 2024Quote: ... D-2-amino-5-phosphonovalerate (D-AP5; 100 µM, Tocris 0106), bicuculline (20 µM ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247; 5 μM SR-95531, Tocris, 1262; 1 μM CGP-55845, Tocris, 1248) were included in the recording solutions.
-
bioRxiv - Developmental Biology 2021Quote: ... NMP differentiation medium was supplemented with and 5 μM Y-27632 (Tocris).
-
bioRxiv - Cell Biology 2021Quote: Cells were treated with the actin inhibitor Cytochalasin-D (5 μM, Tocris), the Ezrin Inhibitor NSC668394 (50 μM ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were refreshed with BPEL supplemented with 5 μM XAV939 (Tocris Bioscience) and 50 ng/ml VEGF (R&D Systems) ...
-
bioRxiv - Physiology 2021Quote: ... SN-401 (DCPIB, 5 mg/kg of body weight/day, Tocris, D1540), SN-403 ...
-
bioRxiv - Developmental Biology 2021Quote: ... for 48 h followed by treatment with IWP2 (5 μM, Tocris, #3533) for an additional 48 h ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5, Tocris Bioscience) were added to the bath to block glutamatergic currents ...
-
bioRxiv - Cell Biology 2020Quote: ... media was changed to R/B-supplemented with 5 uM IWP2 (Tocris) for 48 hours ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Neuroscience 2022Quote: ... D-2-Amino-5-phosphonopentanoic acid (D-AP5, 25 μM; Tocris #0106). These were stored as stock aliquots and diluted in fresh aCSF to their final concentration the day of recording ...
-
bioRxiv - Bioengineering 2022Quote: ... and Nodal/Activin inhibitor (SB431542, Tocris, 1614, 5 µM, days 1-10). On day 2 ...
-
bioRxiv - Neuroscience 2022Quote: ... 20 μM CNQX and 5 μM 5,7-DiCl-kynurenic acid (Tocris, UK). For whole-cell GABAR-mediated currents ...
-
bioRxiv - Neuroscience 2022Quote: ... or 20 μM 2-methylthyo-adenosine-5’-triphosphate (2-MeSATP, Tocris, 1062) over a 5-min period ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [d-Ala2,MePhe4,Gly (ol)5]enkephalin (DAMGO) was purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2023Quote: ... was used to block GluN2A and ifenprodil (5 µM, Tocris, Cat#0545) was used to block GluN2B ...
-
bioRxiv - Neuroscience 2023Quote: ... The selective 5-HT2C receptor antagonist RS102221 (Tocris Bioscience, #1050, Minneapolis, MN) was dissolved in a 50% aCSF and 50% sterile saline solution and infused bilaterally into the aBNST at a dose of 0.5 µg per side [14][14] ...
-
bioRxiv - Systems Biology 2023Quote: ... 10 μM Forskolin (Fisher, BP2520-5) and 100 μM IBMX (Tocris, 2845). Cells were maintained in incubators at 37°C ...
-
bioRxiv - Bioengineering 2023Quote: ... and TGF-Beta inhibitor (SB431542, Tocris # 1614, 5 μM, days 0-7). Media was changed on days 3 and 6 and then every 2-3 days until day 7 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: A CC-chemokine receptor 5 (CCR5) antagonist (maraviroc; Tocris Biosciences, Bristol, UK) was dissolved in dimethyl sulfoxide and diluted with sterile PBS for further use ...
-
bioRxiv - Cell Biology 2023Quote: ... Mitotic exit was induced by adding flavopiridol (Tocris Bioscience, 131740-09-5) to a final concentration of 20 µM ...
-
bioRxiv - Neuroscience 2024Quote: ... and D-2-amino-5-posphonopentanoic acid (APV, 100 μM; Tocris, US) at a holding potential−70 mV (n = 12).
-
bioRxiv - Neuroscience 2024Quote: ... and 5 µM TGF-Beta Inhibitor (SB431542, Tocris # 1614, Days 0-18). Media changes occurred on Days 3 ...
-
bioRxiv - Neuroscience 2024Quote: ... The 5-HT2C receptor antagonist SB242084 (1 μM in 0.5 μL, Tocris) was dissolved in DMSO and diluted in saline (0.01% v/v DMSO) ...
-
bioRxiv - Neuroscience 2024Quote: ... and 50 µM 2-amino-5-phosphonopentanoic acid (D-AP5, Tocris Bioscience) were present in the extracellular solutions to isolate spontaneous IPSCs ...
-
bioRxiv - Neuroscience 2024Quote: ... EdU (10 μM) with or without the acetylcholine (0.5-5 μM, Tocris) was added and incubated for a further 24h ...
-
bioRxiv - Cell Biology 2024Quote: ... either with or without the additional supplementation of 5 nM T3 (Tocris), 100 nM sodium selenite (NaSe ...
-
bioRxiv - Neuroscience 2021Quote: ... We injected 200 nl of 5 mM -(−) bicuculline methiodide (Tocris Bioscience, Bristol, UK) with the syringe pump at 100 nl/min ...
-
bioRxiv - Cell Biology 2021Quote: ... the cells were refreshed with mBEL medium containing 5 µM of XAV939 (Tocris) and 0.25 µM IWP-L6 (AbMole) ...
-
bioRxiv - Neuroscience 2022Quote: ... PTX and the voltage-gated sodium channel blocker tetrodotoxin (TTX, 5 uM, Tocris) were present in the bath ...
-
bioRxiv - Neuroscience 2021Quote: ... hiPSCs were pretreated for 5 days with 3 μM SB431542 (Tocris, Bristol, UK), 3 μM dorsomorphin (Sigma Aldrich) ...
-
bioRxiv - Cell Biology 2020Quote: ... Mitotic cells were then collected and treated with 5 μM ZM447439 (Tocris Biosciences) either with or without 10 ng/mL nocodazole for the time stated before being harvested for immunoblot analyses.
-
bioRxiv - Cell Biology 2021Quote: ... 1 volume of phase separation buffer containing 5 μM A-485 (Tocris, 6387) was added and the mixture incubated for 10 min at room temperature before transferring the suspension to a passivated 384-well microscopy plate well.
-
bioRxiv - Neuroscience 2023Quote: ... and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV, Tocris, 0106) to block glutamatergic inputs ...